RESUMO
Antibiotic treatment has emerged as a promising strategy to sterilize and kill filarial nematodes due to their dependence on their endosymbiotic bacteria, Wolbachia. Several studies have shown that novel and FDA-approved antibiotics are efficacious at depleting the filarial nematodes of their endosymbiont, thus reducing female fecundity. However, it remains unclear if antibiotics can permanently deplete Wolbachia and cause sterility for the lifespan of the adult worms. Concerns about resistance arising from mass drug administration necessitate a careful exploration of potential Wolbachia recrudescence. In the present study, we investigated the long-term effects of the FDA-approved antibiotic, rifampicin, in the Brugia pahangi jird model of infection. Initially, rifampicin treatment depleted Wolbachia in adult worms and simultaneously impaired female worm fecundity. However, during an 8-month washout period, Wolbachia titers rebounded and embryogenesis returned to normal. Genome sequence analyses of Wolbachia revealed that despite the population bottleneck and recovery, no genetic changes occurred that could account for the rebound. Clusters of densely packed Wolbachia within the worm's ovarian tissues were observed by confocal microscopy and remained in worms treated with rifampicin, suggesting that they may serve as privileged sites that allow Wolbachia to persist in worms while treated with antibiotic. To our knowledge, these clusters have not been previously described and may be the source of the Wolbachia rebound.
Assuntos
Brugia pahangi/microbiologia , Filariose/microbiologia , Filaricidas/farmacologia , Rifampina/farmacologia , Wolbachia/efeitos dos fármacos , Animais , Feminino , GerbillinaeRESUMO
The elimination of filarial diseases such as onchocerciasis and lymphatic filariasis is hampered by the lack of a macrofilaricidal-adult worm killing-drug. In the present study, we tested the in vivo efficacy of AN11251, a boron-pleuromutilin that targets endosymbiotic Wolbachia bacteria from filarial nematodes and compared its efficacy to doxycycline and rifampicin. Doxycycline and rifampicin were previously shown to deplete Wolbachia endosymbionts leading to a permanent sterilization of the female adult filariae and adult worm death in human clinical studies. Twice-daily oral treatment of Litomosoides sigmodontis-infected mice with 200 mg/kg AN11251 for 10 days achieved a Wolbachia depletion > 99.9% in the adult worms, exceeding the Wolbachia reduction by 10-day treatments with bioequivalent human doses of doxycycline and a similar reduction as high-dose rifampicin (35 mg/kg). Wolbachia reductions of > 99% were also accomplished by 14 days of oral AN11251 at a lower twice-daily dose (50 mg/kg) or once-per-day 200 mg/kg AN11251 treatments. The combinations tested of AN11251 with doxycycline had no clear beneficial impact on Wolbachia depletion, achieving a > 97% Wolbachia reduction with 7 days of treatment. These results indicate that AN11251 is superior to doxycycline and comparable to high-dose rifampicin in the L. sigmodontis mouse model, allowing treatment regimens as short as 10-14 days. Therefore, AN11251 represents a promising pre-clinical candidate that was identified in the L. sigmodontis model, and could be further evaluated and developed as potential clinical candidate for human lymphatic filariasis and onchocerciasis.
Assuntos
Antibacterianos/farmacologia , Diterpenos/farmacologia , Filariose/tratamento farmacológico , Filarioidea/efeitos dos fármacos , Compostos Policíclicos/farmacologia , Wolbachia/efeitos dos fármacos , Animais , Boro , Doxiciclina/farmacologia , Feminino , Filariose/microbiologia , Filarioidea/microbiologia , Camundongos Endogâmicos BALB C , Rifampina/farmacologia , Simbiose , PleuromutilinasRESUMO
The quinazolines CBR417 and CBR490 were previously shown to be potent anti-wolbachials that deplete Wolbachia endosymbionts of filarial nematodes and present promising pre-clinical candidates for human filarial diseases such as onchocerciasis. In the present study we tested both candidates in two models of chronic filarial infection, namely the Litomosoides sigmodontis and Brugia pahangi jird model and assessed their long-term effect on Wolbachia depletion, microfilariae counts and filarial embryogenesis 16-18 weeks after treatment initiation (wpt). Once per day (QD) oral treatment with CBR417 (50 mg/kg) for 4 days or twice per day (BID) with CBR490 (25 mg/kg) for 7 days during patent L. sigmodontis infection reduced the Wolbachia load by >99% and completely cleared peripheral microfilaremia from 10-14 wpt. Similarly, 7 days of QD treatments (40 mg/kg) with CBR417 or CBR490 cleared >99% of Wolbachia from B. pahangi and reduced peritoneal microfilariae counts by 93% in the case of CBR417 treatment. Transmission electron microscopy analysis indicated intensive damage to the B. pahangi ovaries following CBR417 treatment and in accordance filarial embryogenesis was inhibited in both models after CBR417 or CBR490 treatment. Suboptimal treatment regimens of CBR417 or CBR490 did not lead to a maintained reduction of the microfilariae and Wolbachia load. In conclusion, CBR417 or CBR490 are pre-clinical candidates for filarial diseases, which achieve long-term clearance of Wolbachia endosymbionts of filarial nematodes, inhibit filarial embryogenesis and clear microfilaremia with treatments as short as 7 days.
Assuntos
Antibacterianos/uso terapêutico , Filariose/tratamento farmacológico , Oncocercose/tratamento farmacológico , Quinazolinas/uso terapêutico , Wolbachia/efeitos dos fármacos , Animais , Antibacterianos/administração & dosagem , Brugia pahangi/efeitos dos fármacos , Feminino , Filariose/microbiologia , Filarioidea/efeitos dos fármacos , Gerbillinae/microbiologia , Gerbillinae/parasitologia , Microfilárias/efeitos dos fármacos , Quinazolinas/administração & dosagem , Simbiose/efeitos dos fármacosRESUMO
Human parasitic nematodes are the causative agents of lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness), diseases that are endemic to more than 80 countries and that consistently rank in the top ten for the highest number of years lived with disability. These filarial nematodes have evolved an obligate mutualistic association with an intracellular bacterium, Wolbachia, a symbiont that is essential for the successful development, reproduction, and survival of adult filarial worms. Elimination of the bacteria causes adult worms to die, making Wolbachia a primary target for developing new interventional tools to combat filariases. To further explore Wolbachia as a promising indirect macrofilaricidal drug target, the essential cellular processes that define the symbiotic Wolbachia-host interactions need to be identified. Genomic analyses revealed that while filarial nematodes encode all the enzymes necessary for glycolysis, Wolbachia does not encode the genes for three glycolytic enzymes: hexokinase, 6-phosphofructokinase, and pyruvate kinase. These enzymes are necessary for converting glucose into pyruvate. Wolbachia, however, has the full complement of genes required for gluconeogenesis starting with pyruvate, and for energy metabolism via the tricarboxylic acid cycle. Therefore, we hypothesized that Wolbachia might depend on host glycolysis to maintain a mutualistic association with their parasitic host. We did conditional experiments in vitro that confirmed that glycolysis and its end-product, pyruvate, sustain this symbiotic relationship. Analysis of alternative sources of pyruvate within the worm indicated that the filarial lactate dehydrogenase could also regulate the local intracellular concentration of pyruvate in proximity to Wolbachia and thus help control bacterial growth via molecular interactions with the bacteria. Lastly, we have shown that the parasite's pyruvate kinase, the enzyme that performs the last step in glycolysis, could be a potential novel anti-filarial drug target. Establishing that glycolysis is an essential component of symbiosis in filarial worms could have a broader impact on research focused on other intracellular bacteria-host interactions where the role of glycolysis in supporting intracellular survival of bacteria has been reported.
Assuntos
Brugia/metabolismo , Brugia/microbiologia , Ácido Pirúvico/metabolismo , Wolbachia/metabolismo , Animais , Brugia/genética , Brugia Malayi/genética , Brugia Malayi/metabolismo , Brugia Malayi/microbiologia , Brugia pahangi/genética , Brugia pahangi/metabolismo , Brugia pahangi/microbiologia , Feminino , Filariose/metabolismo , Filariose/microbiologia , Filariose/parasitologia , Genes de Helmintos , Glicólise , Interações entre Hospedeiro e Microrganismos , Interações Hospedeiro-Parasita , Humanos , Masculino , Simbiose , Wolbachia/genéticaRESUMO
Vector-borne transmitted helminthic zoonosis affects the health and economy of both developing and developed countries. The concept of episystem includes the set of biological, environmental, and epidemiological elements of these diseases in defined geographic and temporal scales. Dirofilariasis caused by different species of the genus Dirofilaria is a disease affecting domestic and wild canines and felines and man, transmitted by different species of culicid mosquitoes. This complexity is increased because Dirofilaria species harbor intracellular symbiont Wolbachia bacteriae, which play a key role in the embryogenesis and development of dirofilariae and in the inflammatory pathology of the disease. In addition, the vector transmission makes the dirofilariasis susceptible to the influence of the climate and its variations. The present review addresses the analysis of dirofilariasis from the point of view of the episystem, analyzing the complex network of interactions established between biological components, climate, and factors related to human activity, as well as the different problems they pose. The progress of knowledge on human and animal dirofilariasis is largely due to the multidisciplinary approach. Nevertheless, different aspects of the disease need to continue being investigated and cooperation between countries and specialists involved should be intensified.
Assuntos
Doenças do Cão/microbiologia , Filariose/parasitologia , Zoonoses/parasitologia , Animais , Clima , Culicidae/microbiologia , Culicidae/parasitologia , Dirofilaria/microbiologia , Dirofilaria/patogenicidade , Doenças do Cão/epidemiologia , Doenças do Cão/parasitologia , Doenças do Cão/transmissão , Cães , Filariose/epidemiologia , Filariose/microbiologia , Filariose/transmissão , Humanos , Wolbachia/patogenicidade , Zoonoses/epidemiologia , Zoonoses/microbiologia , Zoonoses/transmissãoRESUMO
Wolbachia is an endosymbiotic bacterium of the filarial nematode Brugia malayi. The symbiotic relationship between Wolbachia and its filarial host is dependent on interactions between the proteins of both organisms. However, little is known about Wolbachia proteins that are involved in the inflammatory pathology of the host during lymphatic filariasis. In the present study, we cloned, expressed and purified Wolbachia surface protein (r-wsp) from Wolbachia and administered it to mice, either alone or in combination with infective larvae of B. malayi (Bm-L3) and monitored the developing immune response in infected animals. Our results show that spleens and mesenteric lymph nodes of mice immunized with either r-wsp or infected with Bm-L3 show increased percentages of CD4(+) T helper type 17 (Th17) cells and Th1 cytokines like interferon-γ and interleukin-2 (IL-2) along with decreased percentages of regulatory T cells, Th2 cytokines like IL-4 and IL-10 and transforming growth factor ß (TGF-ß) levels in culture supernatants of splenocytes. These observations were stronger in mice immunized with r-wsp alone. Interestingly, when mice were first immunized with r-wsp and subsequently infected with Bm-L3, percentages of CD4(+) Th17 cells and Th1 cytokines increased even further while that of regulatory T cells, Th2 cytokines and TGF-ß levels decreased. These results for the first time show that r-wsp acts synergistically with Bm-L3 in promoting a pro-inflammatory response by increasing Th17 cells and at the same time diminishes host immunological tolerance by decreasing regulatory T cells and TGF-ß secretion.
Assuntos
Proteínas da Membrana Bacteriana Externa/farmacologia , Brugia Malayi/imunologia , Brugia Malayi/microbiologia , Filariose/microbiologia , Linfócitos T Reguladores/imunologia , Células Th17/imunologia , Wolbachia/imunologia , Animais , Proteínas da Membrana Bacteriana Externa/biossíntese , Proteínas da Membrana Bacteriana Externa/genética , Clonagem Molecular , Filariose/imunologia , Inflamação/imunologia , Interferon gama/biossíntese , Interleucina-10/biossíntese , Interleucina-2/biossíntese , Interleucina-4/biossíntese , Larva , Linfonodos/imunologia , Linfonodos/microbiologia , Linfonodos/parasitologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/genética , Proteínas Recombinantes/farmacologia , Baço/imunologia , Baço/microbiologia , Baço/parasitologia , Células Th2/imunologia , Fator de Crescimento Transformador beta/biossínteseRESUMO
In Nature, no individual can live in isolation; hence, living organisms are forced to interact with each other. This necessity has led many organisms to establish heterogeneous relations to enhance their ability to adapt to the environment, thus acquiring evolutionary advantages. These relationships are sometimes so intense, that on the long term the organisms may lose their individual identity. An example of these associations is the endosymbiotic ones, where eukaryote organisms generally harbor different prokaryote organisms. The endosymbiotic bacterium Wolbachia pipientis is a species described by Hertig and Wolbach in 1924. This microorganism can be isolated in a large variety of eukaryote organisms, with which it maintains different links. Until now, this species has only been described with 11 serogroups numbered from A to K within the Wolbachia genus. This work is intended to illustrate the relationship of Wolbachia pipientis with human pathogenic filaria and with arthropods, as well as to describe the implications of this bacterium in the treatment of filariasis. Finally, this work tries to describe recent studies that have targeted the use of artificially-created Wolbachia pipientis virulent strains that, once inoculated in infectious diseases-transmitting vectors, develop negative effects within them in order to, in this way, erradicate mosquito-transmitted infectious diseases for which no treatment is available at the moment or the prevention of its transmissibility has not been achieved.
En la naturaleza ningún individuo puede vivir de forma aislada, de tal forma que los organismos vivos se ven obligados a interactuar unos con otros. Esta necesidad ha llevado a que diferentes organismos establezcan relaciones heterogéneas para mejorar su capacidad de adaptación al medio, obteniendo así ventajas evolutivas. Estas relaciones a veces son tan intensas que a la larga los organismos pueden perder su identidad individual. Un ejemplo de estas asociaciones son las endosimbióticas, en las cuales generalmente organismos eucariotas albergan a diferentes organismos procariotas. La bacteria endosimbiótica Wolbachia pipientis es una especie descrita en 1924 por Hertig y Wolbach. Este microorganismo se puede aislar en gran variedad de organismos eucariotas, con los que mantiene diferentes vínculos. Hasta el momento solo se ha descrito esta especie con 11 serogrupos enumerados de la A a la K dentro del género Wolbachia. En este trabajo se pretende ilustrar la relación de Wolbachia pipientis con las filarias patógenas humanas y con los artrópodos, así como describir las implicaciones de esta bacteria en el tratamiento de las filariasis. Finalmente, se pretende exponer los estudios recientes que han apuntado el uso de cepas virulentas de Wolbachia pipientis creadas artificialmente que una vez inoculadas en los vectores transmisores de enfermedades desarrollan efectos negativos en estos, para de esa forma lograr la erradicación de enfermedades infecciosas transmitidas por mosquitos para las cuales de momento no existe tratamiento o no se ha logrado impedir su transmisibilidad.
Assuntos
Artrópodes/microbiologia , Filariose/prevenção & controle , Nematoides/microbiologia , Simbiose , Wolbachia , Animais , Filariose/microbiologia , Filariose/transmissão , HumanosAssuntos
Antígenos de Helmintos/isolamento & purificação , Filariose/microbiologia , Microfilárias/imunologia , Oligodendroglioma/patologia , Wuchereria bancrofti/imunologia , Adulto , Animais , Citodiagnóstico , Humanos , Masculino , Microfilárias/isolamento & purificação , Oligodendroglioma/microbiologia , Wuchereria bancrofti/isolamento & purificaçãoRESUMO
Filariasis causing nematode Brugia malayi is shown to harbor wolbachia bacteria as symbionts. The sequenced genome of the wolbachia endosymbiont from B.malayi (wBm) offers an unprecedented opportunity to identify new wolbachia drug targets. Genome analysis of the glycolytic/gluconeogenic pathway has revealed that wBm lacks pyruvate kinase (PK) and may instead utilize the enzyme pyruvate phosphate dikinase (PPDK; ATP: pyruvate, orthophosphate phosphotransferase, EC 2.7.9.1). PPDK catalyses the reversible conversion of AMP, PPi and phosphoenolpyruvate into ATP, Pi and pyruvate. Most organisms including mammals exclusively possess PK. Therefore the absence of PPDK in mammals makes this enzyme as attractive wolbachia drug target. In the present study we have modeled the three dimensional structure of wBm PPDK. The template with 50% identity and 67% similarity in amino acid sequence was employed for homology-modeling approach. The putative active site consists of His476, Arg360, Glu358, Asp344, Arg112, Lys43 and Glu346 was selected as site of interest for designing suitable inhibitor molecules. Docking studies were carried out using induced fit algorithms with OPLS force field of Schrödinger's Glide. The lead molecules which inhibit the PPDK activity are taken from the small molecule library (Pubchem database) and the interaction analysis showed that these compounds may inhibit the function of PPDK in wBm.
Assuntos
Antibacterianos/farmacologia , Proteínas de Bactérias/genética , Brugia Malayi , Desenho de Fármacos , Filariose/microbiologia , Piruvato Ortofosfato Diquinase/genética , Wolbachia/genética , Algoritmos , Sequência de Aminoácidos , Aminoácidos/metabolismo , Animais , Proteínas de Bactérias/metabolismo , DNA Bacteriano , Bases de Dados Factuais , Genoma Bacteriano , Gluconeogênese/genética , Glicólise/genética , Modelos Moleculares , Dados de Sequência Molecular , Piruvato Ortofosfato Diquinase/metabolismo , Homologia de Sequência , Transdução de Sinais/genética , Simbiose , Wolbachia/enzimologiaRESUMO
Recombinant Wolbachia heat shock protein 60 (rWmhsp60) induces gene expression of pro-inflammatory cytokines IL-1ß, IL-6 and TNF-α in human monocytic cell line THP-1. In addition, it inhibits the phagocytic activity and does not alter the nitric oxide production by differentiated THP-1 macrophages, which corroborates with no significant change in inducible nitric oxide synthase gene expression in rWmhsp60 treated THP-1 monocytes. Further, 24 h stimulation of peripheral blood mononuclear cells from normal individuals by rWmhsp60 reveals that monocytes enter the late apoptotic stage, while lymphocytes do not show apoptosis. Thus these findings suggest that rWmhsp60 may contribute to inflammation mediated monocyte dysfunction in filarial pathogenesis.
Assuntos
Apoptose/fisiologia , Chaperonina 60/metabolismo , Citocinas/biossíntese , Inflamação/microbiologia , Monócitos/imunologia , Wolbachia/metabolismo , Linhagem Celular , Filariose/imunologia , Filariose/microbiologia , Regulação da Expressão Gênica , Humanos , Linfócitos/imunologia , Óxido Nítrico Sintase/genética , Proteínas Recombinantes/metabolismoRESUMO
Filarial infections are characterized by immunopathological phenomena, that are responsible for the onset of often dramatic pathological outcomes, such as blindness (Onchocerca volvulus) and elephantiasis (W. bancrofti). In addition, the long-term survival (as long as 10 years) of these parasites in otherwise immunocompetent hosts indicates that these nematodes are capable of manipulating the host immune response. The ground-breaking discovery of the bacterial endosymbiont Wolbachia, which resides in most filarial nematodes causing disease, has led to increasing interest in the role it may play in immuno-modulation, pro-inflammatory pathology and other aspects of filarial infection. Indeed, Wolbachia has been shown to be responsible for exacerbating inflammation (as in river blindness), while at the same time blocking efficient elimination of parasites through the host immune response (Onchocerca ochengi). While studies aimed at identifying Wolbachia as a potential target for anti-filarial therapy are at the forefront of current research, understanding its role in the immunology of filarial infection is a fascinating field that has yet to uncover many secrets.
Assuntos
Filariose/imunologia , Filariose/microbiologia , Filarioidea/imunologia , Filarioidea/microbiologia , Wolbachia/fisiologia , Animais , Interações Hospedeiro-Parasita/imunologia , Humanos , Imunomodulação/fisiologia , Simbiose/imunologia , Simbiose/fisiologia , Wolbachia/imunologiaRESUMO
Filarial nematode species can host Wolbachia bacterial endosymbionts. To understand the symbiosis, a higher level of complexity should be considered, taking in account the tripartite association between Wolbachia, filariae and mammals. This overview article discusses the biology of Wolbachia in filariae, including their distribution and phylogeny, mechanisms of action, inflammatory consequences on mammal host and biological control implications for filariases. Potential directions for future research are also discussed.
Assuntos
Filariose/tratamento farmacológico , Filariose/microbiologia , Wolbachia/genética , Animais , Anti-Helmínticos/uso terapêutico , Artrópodes/microbiologia , Filariose/transmissão , Filarioidea/genética , Filarioidea/microbiologia , Bactérias Gram-Negativas/isolamento & purificação , Humanos , Vertebrados/parasitologia , Wuchereria bancrofti/microbiologiaRESUMO
BACKGROUND: Thirty-four wild Chlorocebus aethiops monkeys were trapped for research purposes. METHODS: During routine quarantine check-up, cerebrospinal fluid (CSF) and blood were microscopically examined for parasites. Estimations of CSF protein levels were made by the biuret method and the white cell counts by the hemocytometer. RESULTS: Seven monkeys demonstrated microfilariae in blood and CSF. This was accompanied by a two- and ninefold increase in CSF total protein and white cell counts, respectively. Necropsy of one of the blood and CSF microfilariae-positive animals revealed the presence of adult worms in the brain meninges. The parasites were identified as the zoonotic filaroid nematode Meningonema peruzii. CONCLUSIONS: Wild C. aethiops monkeys developed CSF changes resulting, most probably, from infection with M. peruzii. Moreover, the monkeys could be acting as an important reservoir. The study highlights the need for epidemiological and pathogenological studies of this parasite, which is of public health significance. Moreover, C. aethiops proved to be a useful primate model for the study of this zoonotic infection.
Assuntos
Chlorocebus aethiops/líquido cefalorraquidiano , Chlorocebus aethiops/microbiologia , Filariose/veterinária , Microfilárias/isolamento & purificação , Animais , Líquido Cefalorraquidiano/citologia , Proteínas do Líquido Cefalorraquidiano/metabolismo , Chlorocebus aethiops/sangue , Filariose/sangue , Filariose/líquido cefalorraquidiano , Filariose/microbiologia , Leucocitose/líquido cefalorraquidianoRESUMO
This prospective observational study was done during the period from January 2000 to December 2004 including 45 cases of lymphatic filariasis manifested with acute arthritis. Different investigations were carried out to exclude allergy, parasitic and infectious diseases, autoimmune disorder and malignancy. They were given standard treatment with oral non-steroidal anti-inflammatory drugs (NSAIDs). Articular symptoms were not relived satisfactorily. Later they were given oral corticosteroids. During treatment slight relief of symptoms were noted, but all sign-symptoms reappear after withdrawal of corticosteroid drugs. Treatment with oral diethylcarbamazine citrate (DEC) (150 mg/day) for 3 weeks showed complete resolution of arthritis. No side effects or relapse were encountered. The basic mechanism of relief of pain remains unknown. It was assumed that during benign course of lymphatic filariasis, development of arthritis result most likely due to reaction against some occult agents in the joints.
Assuntos
Corticosteroides/uso terapêutico , Anti-Inflamatórios não Esteroides/uso terapêutico , Artrite Infecciosa/etiologia , Dietilcarbamazina/uso terapêutico , Filariose/complicações , Filaricidas/uso terapêutico , Resultado do Tratamento , Doença Aguda , Adulto , Artrite Infecciosa/tratamento farmacológico , Feminino , Filariose/tratamento farmacológico , Filariose/microbiologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos ProspectivosRESUMO
Two of the major filarial infections, lymphatic filariasis (LF) and onchocerciasis, affect 150 million people, while 1 billion living in endemic areas are at risk of infection. Public health programs to control these infections have successfully existed for years and have evolved from activities driven by the WHO into global programs with public-private partnerships. Currently, these programs use yearly mass application of drugs that mainly kill the larval stages (the microfilariae), with the aim of preventing uptake by the transmitting insect vectors and thus, to block transmission and reduce the infections to such levels that in 15-30 years from now, they will no longer pose a public health problem. While the programs have been very successful in general, there are drawbacks such as coverage being too low within the population, reappearance of infection by migration of infected people into controlled areas, targeting of a stage (the microfilaria) that does not induce pathology in LF and thus lowers compliance, and the potential development of drug resistance, first indications of which have been clearly observed in onchocerciasis. In addition, even without drawbacks, program scopes are not the eradication of filarial infections, which is, however, an ultimate goal of control activities. There is therefore an unequivocal call for the development of higher efficient, complementary chemotherapeutical approaches that lead to a long-lasting reduction of the pathology-inducing worm stages; that is, microfilariae in onchocerciasis and adult worms in LF, or to a macrofilaricidal effect. The recent discovery that depletion of Wolbachia endosymbionts by tetracycline antibiotics leads to long-lasting sterility of adult female worms in onchocerciasis and a macrofilaricidal effect in LF fulfils these requirements. Successful regimens have already been published and agreed upon for use by expert panels. While these regimens are still too long for mass application, the antiwolbachial chemotherapy can currently be applied in the form of a suitable doxycycline regimen for 6 weeks for the treatment of individuals, and exploited in the future for the development of new drugs suitable for mass application. In addition, first data suggest that Wolbachia may also be major mediators of lymphangiogenesis and that their depletion is associated with reduction of lymph vessel-specific vascular endothelial growth factors and reduced lymph vessel size.
Assuntos
Doxiciclina/administração & dosagem , Sistemas de Liberação de Medicamentos/tendências , Filariose/tratamento farmacológico , Filaricidas/administração & dosagem , Animais , Doxiciclina/uso terapêutico , Sistemas de Liberação de Medicamentos/métodos , Filariose/microbiologia , Filaricidas/uso terapêutico , HumanosRESUMO
A hospital based open-label clinical trial of 19 apparently healthy adult males with microfilaraemia was conducted to assess safety, tolerability and efficacy of doxycycline on Wuchereria bancrofti. Study individuals were assigned 8 weeks treatment with doxycycline 200 mg daily. The results of different selected tests showed that, the haematological, hepatic, renal and clinical parameters pre-and post-drug administrations were within the normal range for all treated individuals. Clinical adverse events were mild, transient, tolerable and reported in 7/19 (36.8%) of the study cohort. The mf clearance rate was 100% at 12 months post treatment for the 13 individuals who completed the follow up. These findings indicate that, although the drug was administered for a long period, there was no evidence of toxicity to the myocardium, hepatocytes, renal, bone marrow and blood cells, suggesting that an 8-week course of 200 mg/day doxycycline is a safe and tolerable regime for the treatment of Wuchereria bancrofti infections.
Assuntos
Doxiciclina/administração & dosagem , Filariose/tratamento farmacológico , Wuchereria bancrofti/efeitos dos fármacos , Administração Oral , Adolescente , Adulto , Idoso , Animais , Doxiciclina/efeitos adversos , Doxiciclina/uso terapêutico , Avaliação de Medicamentos , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Filariose/microbiologia , Humanos , Masculino , Pessoa de Meia-Idade , Tanzânia , Wuchereria bancrofti/patogenicidadeRESUMO
Filarial nematodes are important helminth parasites of the tropics and a leading cause of global disability. They include species responsible for onchocerciasis, lymphatic filariasis and dirofilariasis. A unique feature of these nematodes is their dependency upon a symbiotic intracellular bacterium, Wolbachia, which is essential for normal development and fertility. Advances in our understanding of the symbiosis of Wolbachia bacteria with filarial nematodes have made rapid progress in recent years. Here we summarise our current understanding of the evolution of the symbiotic association together with insights into the functional basis of the interaction derived from genomic analysis. Also we discuss the contribution of Wolbachia to inflammatory-mediated pathogenesis and adverse reactions to anti-filarial drugs and describe the outcome of recent field trials using antibiotics as a promising new tool for the treatment of filarial infection and disease.
Assuntos
Artrópodes/microbiologia , Filariose , Nematoides/microbiologia , Simbiose , Wolbachia/fisiologia , Animais , Antibacterianos/uso terapêutico , Anticorpos Antibacterianos/biossíntese , Cães , Doxiciclina/uso terapêutico , Meio Ambiente , Filariose/tratamento farmacológico , Filariose/microbiologia , Filariose/parasitologia , Genômica , Humanos , Mediadores da Inflamação/metabolismo , Filogenia , Dinâmica Populacional , Wolbachia/classificação , Wolbachia/efeitos dos fármacos , Wolbachia/crescimento & desenvolvimentoRESUMO
Analisamos a morfologia do intestino médio do mosquito Culex quiquefasciatus de região endêmica e a sua interação com as microfilárias de Wuchereria bancrofti (agente da filariose humana) e de Litomosoides chagasfilhoi (agente de filariose de roedores). O intestino médio está dividido em regiões torácica e abdominal como visto em outras espécies de mosquitos. Porém, o intestino médio torácico é formado por dois tipos celulares: células principais e basais; e o intestino médio abdominal por três tipos: células principais clara e basais. Existe uma rede muscular organizar revestindo externamente o órgão, a qual sofre mudanças irreversíveis no intestino médio abdominal após o repasto sangüíneo. A estrutura da matriz peritrófica e a sua formação induzida pela alimentação sangüínea são distintas das demais espécies de mosquitos. O L. chagasfilhoi invade o intestino médio entre 1h e 3h após o repasto infectivo, enquanto que a W. bancrofti entre 30 minutos e 5 horas com o maior número de invasão nas primeiras 2 horas. O L. chagasfilhoi preferencialmente invade o intestino médio abdominal enquanto que a W. bancrofti invade o intestino médio torácico, principalmente perto da região abdominal. Ambas espécies de microfilárias cruzam o intestino médio através do espaço intercelular, causando hipertrofia e extrusão de uma a duas células epiteliais. A perda da bainha pelas microfilárias de ambas espécies não é um pré-requisito para a evasão do intestino. Etapas subseqüentes do ciclo da W. bancrofti, tais como, a melanização na hemocele e a invasão precoce da musculatura de vôo foram também observadas. Não foi possível observar tais etapas nos mosquitos infectados com L. chagasfilhoi porque eles morreram poucas horas após a invasão do intestino médio. Estas diferenças no processo de interação das espécies de microfilárias provavelmente estão relacionados com a capacidade vetorial do mosquito
Assuntos
Culex/ultraestrutura , Filariose/microbiologia , Filariose/parasitologia , Insetos Vetores , Wuchereria bancrofti/crescimento & desenvolvimento , Wuchereria bancrofti/imunologia , Wuchereria bancrofti/parasitologiaRESUMO
Analisamos a morfologia do intestino médio do mosquito Culex quiquefasciatus de região endêmica e a sua interação com as microfilárias de Wuchereria bancrofti (agente da filariose humana) e de Litomosoides chagasfilhoi (agente de filariose de roedores). O intestino médio está dividido em regiões torácica e abdominal como visto em outras espécies de mosquitos. Porém, o intestino médio torácico é formado por dois tipos celulares: células principais e basais; e o intestino médio abdominal por três tipos: células principais clara e basais. Existe uma rede muscular organizada revestindo externamente o órgão, a qual sofre mudanças irreversíveis no intestino médio abdominal após o repasto sangüíneo. A estrutura da matriz peritrófica e a sua formação induzida pela alimentação sangüínea são distintas das demais espécies de mosquitos. O L. chagasfilhoi invade o intestino médio entre 1h e 3h após o repasto infectivo, enquanto que a W. bancrofti entre 30 minutos e 5 horas com o maior número de invasão nas primeiras 2 horas. O L. chagasfilhoi preferencialmente invade o intestino médio abdominal enquanto que a W. bancrofti invade o intestino médio torácico, principalmente perto da região abdominal. Ambas espécies de microfilárias cruzam o intestino médio através do espaço intercelular, causando hipertrofia e extrusão de uma a duas células epiteliais. A perda da bainha pelas microfilárias de ambas espécies não é um pré-requisito para a evasão do intestino. Etapas subseqüentes do ciclo da W. bancrofti, tais como, a melanização na hemocele e a invasão precoce da musculatura de vôo foram também observadas. Não foi possível observar tais etapas nos mosquitos infectados com L. chagasfilhoi porque eles morreram poucas horas após a invasão do intestino médio. Estas diferenças no processo de interação das espécies de microfilárias provavelmente estão relacionados com a capacidade vetorial do mosquito.